BINOL-Salen-catalyzed highly enantioselective alkyne additions to aromatic aldehydes.
Org Lett.
2004 Mar 18;6(6):1065-8. doi: 10.1021/ol0498139. PubMed PMID:
15012101.
Macrocyclic bisbinaphthyl fluorophores and their acyclic analogues: signal amplification and chiral recognition.
J Org Chem.
2004 Sep 17;69(19):6284-93. doi: 10.1021/jo049366a. PubMed PMID:
15357587.
A cyclohexyl-1,2-diamine-derived bis(binaphthyl) macrocycle: enhanced sensitivity and enantioselectivity in the fluorescent recognition of mandelic acid.
Angew Chem Int Ed Engl.
2005 Mar 4;44(11):1690-3. doi: 10.1002/anie.200462471. PubMed PMID:
15688352.
Enantioselective fluorescent recognition of a soluble "supported" chiral acid: toward a new method for chiral catalyst screening.
Org Lett.
2005 Aug 4;7(16):3441-4. doi: 10.1021/ol0510163. PubMed PMID:
16048312.
Are quantum dots ready for in vivo imaging in human subjects?.
Nanoscale Res Lett.
2007 Jun;2(6):265-281. doi: 10.1007/s11671-007-9061-9. PubMed PMID:
21394238; PubMed Central PMCID:
PMC3050636.
Chiral macrocycle-catalyzed highly enantioselective phenylacetylene addition to aliphatic and vinyl aldehydes.
J Org Chem.
2007 Jun 8;72(12):4340-3. doi: 10.1021/jo070091j. Epub 2007 May 11. PubMed PMID:
17497801.
Enantioselective fluorescent recognition of chiral acids by cyclohexane-1,2-diamine-based bisbinaphthyl molecules.
J Org Chem.
2007 Jun 22;72(13):4905-16. doi: 10.1021/jo0704715. Epub 2007 May 27. PubMed PMID:
17530897; PubMed Central PMCID:
PMC2536617.
(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
J Nucl Med.
2007 Jul;48(7):1162-71. doi: 10.2967/jnumed.107.039859. Epub 2007 Jun 15. PubMed PMID:
17574975.
microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
J Nucl Med.
2007 Sep;48(9):1536-44. doi: 10.2967/jnumed.107.040816. Epub 2007 Aug 17. PubMed PMID:
17704249; PubMed Central PMCID:
PMC4183663.
64Cu-Labeled triphenylphosphonium and triphenylarsonium cations as highly tumor-selective imaging agents.
J Med Chem.
2007 Oct 18;50(21):5057-69. doi: 10.1021/jm0704088. Epub 2007 Sep 15. PubMed PMID:
17867662.
Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
J Nucl Med.
2007 Nov;48(11):1862-70. doi: 10.2967/jnumed.107.043216. Epub 2007 Oct 17. PubMed PMID:
17942800.
PET imaging of acute and chronic inflammation in living mice.
Eur J Nucl Med Mol Imaging.
2007 Nov;34(11):1832-42. doi: 10.1007/s00259-007-0451-0. Epub 2007 May 31. PubMed PMID:
17541586.
18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
Eur J Nucl Med Mol Imaging.
2007 Nov;34(11):1823-1831. doi: 10.1007/s00259-007-0427-0. Epub 2007 May 5. PubMed PMID:
17492285; PubMed Central PMCID:
PMC4167588.
Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression.
Bioconjug Chem.
2007 Nov-Dec;18(6):1987-94. doi: 10.1021/bc700226v. Epub 2007 Nov 21. PubMed PMID:
18030991; PubMed Central PMCID:
PMC4183694.
18F-labeled BBN-RGD heterodimer for prostate cancer imaging.
J Nucl Med.
2008 Mar;49(3):453-61. doi: 10.2967/jnumed.107.048009. Epub 2008 Feb 20. PubMed PMID:
18287274.
The synthesis of 18F-FDS and its potential application in molecular imaging.
Mol Imaging Biol.
2008 Mar-Apr;10(2):92-98. doi: 10.1007/s11307-007-0125-0. Epub 2007 Dec 21. PubMed PMID:
18097725; PubMed Central PMCID:
PMC4143166.
Imaging of VEGF receptor in a rat myocardial infarction model using PET.
J Nucl Med.
2008 Apr;49(4):667-73. doi: 10.2967/jnumed.107.040576. PubMed PMID:
18375924; PubMed Central PMCID:
PMC2853914.
Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis.
Nucleic Acids Res.
2008 May;36(8):2764-76. doi: 10.1093/nar/gkn115. Epub 2008 Mar 26. PubMed PMID:
18367474; PubMed Central PMCID:
PMC2377441.
Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein.
Mol Cancer Ther.
2008 May;7(5):1044-53. doi: 10.1158/1535-7163.MCT-07-2084. PubMed PMID:
18483294.
Effects of targeting moiety, linker, bifunctional chelator, and molecular charge on biological properties of 64Cu-labeled triphenylphosphonium cations.
J Med Chem.
2008 May 22;51(10):2971-84. doi: 10.1021/jm7015045. Epub 2008 Apr 18. PubMed PMID:
18419113.
(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression.
Eur J Nucl Med Mol Imaging.
2008 Jun;35(6):1100-8. doi: 10.1007/s00259-007-0692-y. Epub 2008 Jan 19. PubMed PMID:
18204838.
Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET.
Clin Cancer Res.
2008 Aug 1;14(15):4758-66. doi: 10.1158/1078-0432.CCR-07-4434. PubMed PMID:
18676745.
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer.
Eur J Nucl Med Mol Imaging.
2008 Aug;35(8):1489-98. doi: 10.1007/s00259-008-0744-y. Epub 2008 Mar 29. PubMed PMID:
18373091.
PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic (RGD)-conjugated radiolabeled iron oxide nanoparticles.
J Nucl Med.
2008 Aug;49(8):1371-9. doi: 10.2967/jnumed.108.051243. Epub 2008 Jul 16. PubMed PMID:
18632815.
64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.
Bioconjug Chem.
2008 Oct;19(10):2008-22. doi: 10.1021/bc8002056. Epub 2008 Sep 3. PubMed PMID:
18763821; PubMed Central PMCID:
PMC2637998.
Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots.
Eur J Nucl Med Mol Imaging.
2008 Dec;35(12):2235-44. doi: 10.1007/s00259-008-0860-8. Epub 2008 Jun 20. PubMed PMID:
18566815.
Positron emission tomography imaging of poststroke angiogenesis.
Stroke.
2009 Jan;40(1):270-7. doi: 10.1161/STROKEAHA.108.517474. Epub 2008 Oct 23. PubMed PMID:
18948613.
Quantitative PET imaging of VEGF receptor expression.
Mol Imaging Biol.
2009 Jan-Feb;11(1):15-22. doi: 10.1007/s11307-008-0172-1. Epub 2008 Sep 11. PubMed PMID:
18784964.
MicroPET, MicroSPECT, and NIR fluorescence imaging of biomolecules in vivo.
Methods Mol Biol.
2009;544:461-81. doi: 10.1007/978-1-59745-483-4_31. PubMed PMID:
19488719.
Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.
Cancer Res.
2009 Apr 1;69(7):2709-13. doi: 10.1158/0008-5472.CAN-08-4122. Epub 2009 Mar 24. PubMed PMID:
19318556; PubMed Central PMCID:
PMC2866177.
PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
J Nucl Med.
2009 Jul;50(7):1116-23. doi: 10.2967/jnumed.109.061820. Epub 2009 Jun 12. PubMed PMID:
19525473; PubMed Central PMCID:
PMC6435376.
Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
J Nucl Med.
2009 Jul;50(7):1168-77. doi: 10.2967/jnumed.108.061739. Epub 2009 Jun 12. PubMed PMID:
19525469.
Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with (64)Cu-DOTA-trastuzumab.
Eur J Nucl Med Mol Imaging.
2009 Sep;36(9):1510-9. doi: 10.1007/s00259-009-1158-1. Epub 2009 May 14. PubMed PMID:
19440708; PubMed Central PMCID:
PMC3596115.
64Cu-labeled PEGylated polyethylenimine for cell trafficking and tumor imaging.
Mol Imaging Biol.
2009 Nov-Dec;11(6):415-23. doi: 10.1007/s11307-009-0228-x. Epub 2009 May 9. PubMed PMID:
19430846.
An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
Nucl Med Biol.
2010 Jan;37(1):57-65. doi: 10.1016/j.nucmedbio.2009.09.001. Epub 2009 Oct 12. PubMed PMID:
20122669.
Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.
Bioconjug Chem.
2010 Aug 18;21(8):1417-24. doi: 10.1021/bc900537f. PubMed PMID:
20666401.
Radiopharmaceutical chemistry for positron emission tomography.
Adv Drug Deliv Rev.
2010 Aug 30;62(11):1031-51. doi: 10.1016/j.addr.2010.09.007. Epub 2010 Sep 18. Review. PubMed PMID:
20854860.
Theranostic agents that co-deliver therapeutic and imaging agents?.
Adv Drug Deliv Rev.
2010 Aug 30;62(11):1003-4. doi: 10.1016/j.addr.2010.10.001. Epub 2010 Oct 16. PubMed PMID:
20937334.
Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes.
Chem Commun (Camb).
2010 Nov 14;46(42):8043-5. doi: 10.1039/c0cc03078c. Epub 2010 Sep 22. PubMed PMID:
20862423; PubMed Central PMCID:
PMC3230320.
(64)Cu labeled AmBaSar-RGD2 for micro-PET imaging of integrin αvβ3 expression.
Curr Radiopharm.
2011 Jan;4(1):68-74. doi: 10.2174/1874471011104010068. PubMed PMID:
22191616.
Improved synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]FMAU).
Curr Radiopharm.
2011 Jan;4(1):24-30. doi: 10.2174/1874471011104010024. PubMed PMID:
22191612.
Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module.
Nucl Med Biol.
2011 Feb;38(2):201-6. doi: 10.1016/j.nucmedbio.2010.08.010. Epub 2010 Dec 3. PubMed PMID:
21315275.
Biological stability evaluation of the α2β1 receptor imaging agents: diamsar and DOTA conjugated DGEA peptide.
Bioconjug Chem.
2011 Feb 16;22(2):256-63. doi: 10.1021/bc100388g. Epub 2011 Jan 18. PubMed PMID:
21244039.
The improved syntheses of 5-substituted 2'-[18F]fluoro-2'-deoxy-arabinofuranosyluracil derivatives ([18F]FAU, [18F]FEAU, [18F]FFAU, [18F]FCAU, [18F]FBAU and [18F]FIAU) using a multistep one-pot strategy.
Nucl Med Biol.
2011 Jul;38(5):659-66. doi: 10.1016/j.nucmedbio.2011.01.003. Epub 2011 Mar 30. PubMed PMID:
21718941.
Design, synthesis and validation of integrin α2β1-targeted probe for microPET imaging of prostate cancer.
Eur J Nucl Med Mol Imaging.
2011 Jul;38(7):1313-22. doi: 10.1007/s00259-011-1752-x. Epub 2011 Feb 25. PubMed PMID:
21350963.
Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.
Mol Imaging.
2011 Aug;10(4):284-94. doi: 10.2310/7290.2010.00044. Epub 2011 Apr 1. PubMed PMID:
21486537.
In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
Bioconjug Chem.
2011 Aug 17;22(8):1587-94. doi: 10.1021/bc200132t. Epub 2011 Jul 14. PubMed PMID:
21692471.
Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ₃ targeted PET tracer based on a cyclic RGD peptide.
Bioorg Med Chem Lett.
2011 Sep 1;21(17):5011-4. doi: 10.1016/j.bmcl.2011.04.116. Epub 2011 May 4. PubMed PMID:
21601452; PubMed Central PMCID:
PMC3230322.
Efficient preparation and biological evaluation of a novel multivalency bifunctional chelator for 64Cu radiopharmaceuticals.
Chemistry.
2011 Sep 5;17(37):10222-5. doi: 10.1002/chem.201101894. Epub 2011 Aug 4. PubMed PMID:
21815227; PubMed Central PMCID:
PMC5367772.
Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging.
Chem Commun (Camb).
2011 Sep 7;47(33):9324-6. doi: 10.1039/c1cc13089g. Epub 2011 Jul 21. PubMed PMID:
21779546.
What would you like to do?